HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xubo Yuan Selected Research

Xubo Yuan Research Topics

Disease

20Neoplasms (Cancer)
01/2022 - 05/2010
7Glioma (Gliomas)
01/2022 - 05/2010
4Glioblastoma (Glioblastoma Multiforme)
11/2022 - 10/2011
3Wounds and Injuries (Trauma)
09/2023 - 01/2018
3Brain Neoplasms (Brain Tumor)
01/2022 - 05/2019
2Hemorrhage
12/2023 - 07/2022
2Osteoporotic Fractures
08/2023 - 09/2020
2Inflammation (Inflammations)
08/2023 - 01/2021
2Infections
08/2018 - 01/2018
2Bacterial Infections (Bacterial Infection)
06/2018 - 01/2018
1Hematoma
08/2023
1Cognitive Dysfunction
01/2023
1Fatigue
01/2023
1Brain Concussion (Cerebral Concussion)
01/2023
1Atrophy
01/2023
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022
1Neoplasm Metastasis (Metastasis)
01/2022
1Breast Neoplasms (Breast Cancer)
01/2022
1Cardiotoxicity
01/2021
1Ischemic Stroke
01/2021
1Weight Loss (Weight Reduction)
01/2021
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2021
1Stroke (Strokes)
01/2021
1Cerebral Hemorrhage
03/2019
1Bone Fractures (Bone Fracture)
03/2019
1Lymphoma (Lymphomas)
01/2019
1Leukemia
01/2019
1Hematologic Neoplasms (Hematological Malignancy)
01/2019

Drug/Important Bio-Agent (IBA)

10NanocapsulesIBA
08/2023 - 01/2015
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 02/2014
4MicroRNAs (MicroRNA)IBA
04/2016 - 02/2014
3HydrogelsIBA
09/2023 - 07/2022
3Peptides (Polypeptides)IBA
08/2023 - 01/2019
2Hemostatics (Antihemorrhagics)IBA
12/2023 - 07/2022
2Matrix Metalloproteinases (MMPs)IBA
08/2023 - 03/2019
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2023 - 03/2019
2LipidsIBA
01/2022 - 01/2021
2Monoclonal AntibodiesIBA
01/2022 - 05/2019
2Choline (Choline Chloride)IBA
01/2022 - 05/2019
2Therapeutic UsesIBA
01/2022 - 01/2020
2Poly(amidoamine)IBA
01/2021 - 05/2010
2PAMAM StarburstIBA
01/2021 - 05/2010
2Dendrimers (Dendrons)IBA
01/2021 - 05/2010
2Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 10/2011
1Free RadicalsIBA
08/2023
1Phosphorylcholine (Phosphocholine)IBA
08/2023
1Immunoglobulin G (IgG)IBA
01/2023
1Immunoglobulins (Immunoglobulin)IBA
01/2023
1Small Interfering RNA (siRNA)IBA
11/2022
1Metformin (Glucophage)FDA LinkGeneric
11/2022
1ChitosanIBA
07/2022
1PowdersIBA
07/2022
1MicrogelsIBA
07/2022
1Nanoparticle Drug Delivery SystemIBA
01/2022
1Evans Blue (Blue, Evans)FDA Link
01/2022
1Lipocalin-2IBA
01/2022
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
01/2022
1Paclitaxel (Taxol)FDA LinkGeneric
01/2022
1Liposomes (Liposome)IBA
01/2022
1CY5.5 cyanine dyeIBA
01/2022
1poly(2- methacryloyloxyethyl- phosphorylcholine)IBA
01/2021
1Membrane LipidsIBA
01/2021
1Phosphatidylcholines (Phosphatidylcholine)IBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1SolutionsIBA
01/2021
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2021
1arginine deiminaseIBA
12/2020
1Arginine (L-Arginine)FDA Link
12/2020
1Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA
12/2020
1EnzymesIBA
12/2020
1Amino AcidsFDA Link
12/2020
1Cetuximab (Erbitux)FDA Link
01/2020
1AntibodiesIBA
01/2020
1Acetylcholine (Acetylcholine Chloride)FDA Link
05/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Granzymes (Granzyme)IBA
01/2019
1Durapatite (Hydroxylapatite)IBA
01/2018
1Biocompatible Materials (Biomaterials)IBA
01/2018
1MethyltransferasesIBA
04/2015
1DNA (Deoxyribonucleic Acid)IBA
04/2015
1HematoporphyrinsIBA
03/2014
1poly(lactide)- b- poly(N,N- dimethylamino- 2- ethyl methacrylate)IBA
02/2014
1MicellesIBA
02/2014
1Temozolomide (Temodar)FDA LinkGeneric
09/2012
1Transferrin (beta 2 Transferrin)IBA
01/2012
1PolymersIBA
01/2012
1Carmustine (FIVB)FDA Link
01/2012
1TCF Transcription FactorsIBA
10/2011
1Annexin A5IBA
10/2011
1thiazolyl blueIBA
10/2011

Therapy/Procedure

19Therapeutics
11/2022 - 05/2010
2Drug Therapy (Chemotherapy)
01/2021 - 01/2012
2Intravenous Administration
04/2016 - 03/2014
1Injections
09/2023
1Lasers (Laser)
01/2022
1Immunomodulation
01/2021
1Immunotherapy
01/2019
1Orthopedic Procedures
08/2018
1Prostheses and Implants (Prosthesis)
06/2018
1Combination Drug Therapy (Combination Chemotherapy)
01/2012